Abstract
Diagnostic and prognostic values of Kruppel-like factor 5 (KLF5) and Runt-related transcription factor 1 (RUNX1) were determined in sepsis-induced acute kidney injury (SI-AKI). The study included 120 septic patients and set two groups: SI-AKI group (n = 60) or non-AKI group (n = 60). Fasting venous blood was drawn, and KLF5 and RUNX1 levels were measured. The receiver operating characteristic curve was plotted for diagnostic evaluation of KLF5 and RUNX1 in SI-AKI. The correlation between KLF5 and RUNX1 and serum creatinine (Scr), cystatin C (Cys-C), and kidney injury molecule 1 (KIM-1) were assessed by Pearson method. Predictive values of KLF5 and RUNX1 in 28-day survival of SI-AKI patients were considered by Kaplan-Meier survival curves and multivariate Cox regression analysis. Serum KLF5 and RUNX1 in SI-AKI patients were upregulated. Serum KLF5 and RUNX1 were of high diagnostic value in distinguishing SI-AKI patients from non-AKI patients. KLF5 and RUNX1 were in a positive correlation with Scr, Cys-C, and KIM-1, respectively. The 28-day survival of SI-AKI patients with high serum KLF5 or RUNX1 expression was poor, and serum KLF5 and RUNX1 expression were independently correlated with SI-AKI patients’ survival. KLF5 and RUNX1 have diagnostic and prognostic values in SI-AKI patients.
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.
References
Zarbock, A., Koyner, J. L., Gomez, H., Pickkers, P., & Forni, L. (2023). Sepsis-associated acute kidney injury-treatment standard. Nephrology Dialysis Transplantation, 39(1), 26–35. https://doi.org/10.1093/ndt/gfad142
Desanti De Oliveira, B., Xu, K., Shen, T. H., et al. (2019). Molecular nephrology: Types of acute tubular injury. Nature Reviews Nephrology, 15(10), 599–612. https://doi.org/10.1038/s41581-019-0184-x
Uchino, S., Kellum, J. A., Bellomo, R., et al. (2005). Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA, 294(7), 813–818. https://doi.org/10.1001/jama.294.7.813
Yu, H., Jin, F., Liu, D., et al. (2020). ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics, 10(5), 2342–2357. https://doi.org/10.7150/thno.40395
Kellum, J. A., Chawla, L. S., Keener, C., et al. (2016). The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. American Journal of Respiratory and Critical Care Medicine, 193(3), 281–287. https://doi.org/10.1164/rccm.201505-0995OC
Hoste, E. A., Lameire, N. H., Vanholder, R. C., Benoit, D. D., Decruyenaere, J. M., & Colardyn, F. A. (2003). Acute renal failure in patients with sepsis in a surgical ICU: Predictive factors, incidence, comorbidity, and outcome. Journal of the American Society of Nephrology, 14(4), 1022–1030. https://doi.org/10.1097/01.asn.0000059863.48590.e9
Peerapornratana, S., Manrique-Caballero, C. L., Gómez, H., & Kellum, J. A. (2019). Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney International, 96(5), 1083–1099. https://doi.org/10.1016/j.kint.2019.05.026
Baxmann, A. C., Ahmed, M. S., Marques, N. C., et al. (2008). Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clinical journal of the American Society of Nephrology: CJASN, 3(2), 348–354. https://doi.org/10.2215/cjn.02870707
Vaidya, V. S., Ferguson, M. A., & Bonventre, J. V. (2008). Biomarkers of acute kidney injury. Annual Review of Pharmacology and Toxicology, 48, 463–493. https://doi.org/10.1146/annurev.pharmtox.48.113006.094615
Murray, P. T., Mehta, R. L., Shaw, A., et al. (2014). Potential use of biomarkers in acute kidney injury: Report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney International, 85(3), 513–521. https://doi.org/10.1038/ki.2013.374
Zhang, W. R., & Parikh, C. R. (2019). Biomarkers of acute and chronic kidney disease. Annual Review of Physiology, 81, 309–333. https://doi.org/10.1146/annurev-physiol-020518-114605
Bellomo, R., Kellum, J. A., Ronco, C., et al. (2017). Acute kidney injury in sepsis. Intensive Care Medicine, 43(6), 816–828. https://doi.org/10.1007/s00134-017-4755-7
Bihorac, A., Chawla, L. S., Shaw, A. D., et al. (2014). Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. American Journal of Respiratory and Critical Care Medicine, 189(8), 932–939. https://doi.org/10.1164/rccm.201401-0077OC
Ostermann, M., McCullough, P. A., Forni, L. G., et al. (2018). Kinetics of urinary cell cycle arrest markers for acute kidney injury following exposure to potential renal insults. Critical Care Medicine, 46(3), 375–383. https://doi.org/10.1097/ccm.0000000000002847
Johnson, A. C. M., & Zager, R. A. (2018). Mechanisms underlying increased TIMP2 and IGFBP7 urinary excretion in experimental AKI. Journal of the American Society of Nephrology, 29(8), 2157–2167. https://doi.org/10.1681/asn.2018030265
Pollak, N. M., Hoffman, M., Goldberg, I. J., & Drosatos, K. (2018). Krüppel-like factors: Crippling and un-crippling metabolic pathways. JACC Basic to Translational Science, 3(1), 132–156. https://doi.org/10.1016/j.jacbts.2017.09.001
Conkright, M. D., Wani, M. A., Anderson, K. P., & Lingrel, J. B. (1999). A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Research, 27(5), 1263–1270. https://doi.org/10.1093/nar/27.5.1263
Sogawa, K., Imataka, H., Yamasaki, Y., Kusume, H., Abe, H., & Fujii-Kuriyama, Y. (1993). cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Research, 21(7), 1527–1532. https://doi.org/10.1093/nar/21.7.1527
Li, J., Liu, L., Zhou, W. Q., Cai, L., Xu, Z. G., & Rane, M. J. (2021). Roles of Krüppel-like factor 5 in kidney disease. Journal of Cellular and Molecular Medicine, 25(5), 2342–2355. https://doi.org/10.1111/jcmm.16332
Ban, K. Y., Nam, G. Y., Kim, D., Oh, Y. S., & Jun, H. S. (2022). Prevention of LPS-induced acute kidney injury in mice by bavachin and its potential mechanisms. Antioxidants (Basel), 11(11). https://doi.org/10.3390/antiox11112096
Hong, D., Fritz, A. J., Finstad, K. H., et al. (2018). Suppression of breast cancer stem cells and tumor growth by the RUNX1 transcription factor. Molecular Cancer Research: MCR, 16(12), 1952–1964. https://doi.org/10.1158/1541-7786.Mcr-18-0135
Luo, M. C., Zhou, S. Y., Feng, D. Y., et al. (2016). Runt-related transcription factor 1 (RUNX1) binds to p50 in macrophages and enhances TLR4-triggered inflammation and septic shock. Journal of Biological Chemistry, 291(42), 22011–22020. https://doi.org/10.1074/jbc.M116.715953
Zhou, T., Luo, M., Cai, W., et al. (2018). Runt-related transcription factor 1 (RUNX1) promotes TGF-β-induced renal tubular epithelial-to-mesenchymal transition (EMT) and renal fibrosis through the PI3K subunit p110δ. EBioMedicine, 31, 217–225. https://doi.org/10.1016/j.ebiom.2018.04.023
Zhang, Y., Huang, H., Liu, W., et al. (2021). Endothelial progenitor cells-derived exosomal microRNA-21-5p alleviates sepsis-induced acute kidney injury by inhibiting RUNX1 expression. Cell Death & Disease, 12(4), 335. https://doi.org/10.1038/s41419-021-03578-y
Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550. https://doi.org/10.1186/s13059-014-0550-8
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010). edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26(1), 139–140. https://doi.org/10.1093/bioinformatics/btp616
Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 315(8), 801–810. https://doi.org/10.1001/jama.2016.0287
Mehta, R. L., Kellum, J. A., Shah, S. V., et al. (2007). Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Critical Care, 11(2), R31. https://doi.org/10.1186/cc5713
Chen, W. Y., Cai, L. H., Zhang, Z. H., et al. (2021). The timing of continuous renal replacement therapy initiation in sepsis-associated acute kidney injury in the intensive care unit: The CRTSAKI study (continuous RRT timing in sepsis-associated AKI in ICU): Study protocol for a multicentre, randomised controlled trial. BMJ Open, 11(2), e040718. https://doi.org/10.1136/bmjopen-2020-040718
He, F. F., Wang, Y. M., Chen, Y. Y., Huang, W., Li, Z. Q., & Zhang, C. (2022). Sepsis-induced AKI: From pathogenesis to therapeutic approaches. Frontiers in Pharmacology, 13, 981578. https://doi.org/10.3389/fphar.2022.981578
Cobussen, M., Verhave, J. C., Buijs, J., & Stassen, P. M. (2023). The incidence and outcome of AKI in patients with sepsis in the emergency department applying different definitions of AKI and sepsis. International Urology and Nephrology, 55(1), 183–190. https://doi.org/10.1007/s11255-022-03267-5
Rane, M. J., Zhao, Y., & Cai, L. (2019). Krϋppel-like factors (KLFs) in renal physiology and disease. EBioMedicine, 40, 743–750. https://doi.org/10.1016/j.ebiom.2019.01.021
Formica, C., Malas, T., Balog, J., Verburg, L., t’Hoen, P. A. C., & Peters, D. J. M. (2019). Characterisation of transcription factor profiles in polycystic kidney disease (PKD): Identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression. Journal of Molecular Medicine, 97(12), 1643–1656. https://doi.org/10.1007/s00109-019-01852-3
Author information
Authors and Affiliations
Contributions
J Hu designed the research study. Y Lin and Y Wang performed the research. Y Shi and X Shi provided help and advice on the experiments. J Hu and B Wu analyzed the data. J Hu wrote the manuscript. B Wu reviewed and edited the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
The present study was approved by the Ethics Committee of The Third Affiliated Hospital of Sun Yat-sen University, and written informed consent was provided by all patients prior to the study start. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and The Declaration of Helsinki, and its later amendments or comparable ethical standards.
Consent for Publication
Written informed consent for publication was obtained from all participants.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
Supplementary Figure 1 Results of bioinformatics analysis. A: Differentially expressed genes between Non-AKI and SI-AKI; B-C: KLF5 and RUNX1 were significantly upregulated in SI-AKI. (TIF 3430 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hu, J., Lin, Y., Wang, Y. et al. Diagnostic and Prognostic Values of KLF5 and RUNX1 in Acute Kidney Injury in Septic Patients. Appl Biochem Biotechnol (2024). https://doi.org/10.1007/s12010-024-04956-w
Accepted:
Published:
DOI: https://doi.org/10.1007/s12010-024-04956-w